A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Virtual Tribunal Monastery
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
New York Medical College
Duke University
Roswell Park Cancer Institute